Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen

• Published in: Blood coagulation & fibrinolysis Vol. 34; no. 5; pp. 337 - 344
• Main Authors: Marin, Maximo J., Mathew, Carol M., Rajasekhar, Anita, Zumberg, Marc, Euliano, Tammy Y., Winter, William E., Pelletier, J. Peter R., Pruitt, Heather D., Harris, Neil S.
• Format: Journal Article
• Language: English
• Published: England Lippincott Williams & Wilkins 01-07-2023
• Subjects: Afibrinogenemia - diagnosis; Fibrinogen - analysis; Fibrinogen - therapeutic use; Hemorrhage - etiology; Hemostatics; Humans; Thrombosis
• ISSN: 0957-5235; 1473-5733
• DOI: 10.1097/MBC.0000000000001237

Inherited dysfibrinogenemias are molecular disorders of fibrinogen that affect fibrin polymerization. The majority of cases are asymptomatic, but a significant proportion suffer from increased bleeding or thrombosis. We present two unrelated cases of dysfibrinogenemia, both of whom showed a characteristic discrepancy between fibrinogen activity and the immunologic fibrinogen. In one patient, the dysfibrinogenemia was confirmed by molecular analysis; in the other case, the diagnosis was presumptive based upon laboratory studies. Both patients underwent elective surgery. Both received a highly purified fibrinogen concentrate preoperatively and demonstrated a suboptimal laboratory response to the infusion. Three methods for determining fibrinogen concentration (Clauss fibrinogen, prothrombin-derived fibrinogen, and the viscoelastic functional fibrinogen) were utilized in the case of one patient, and these techniques showed discrepant results with the classic Clauss method giving the lowest concentration. Neither patient experienced excessive bleeding during surgery. Although these discrepancies have been previously described in untreated patients, their manifestation after infusion of purified fibrinogen is less well appreciated.